Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene
Authors:
- Galit Rozenfeld-GranotGRGalit Rozenfeld-Granot
- Izhar HardanIHIzhar Hardan
- Frida Brok-SimoniFBFrida Brok-Simoni
- Ninette AmariglioNANinette Amariglio
- Gideon RechaviGRGideon Rechavi
- Luba TrakhtenbrotLTLuba Trakhtenbrot
- 1 July 2001
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 128 (2) , 114-119
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridizationCancer Genetics and Cytogenetics, 2000
- Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemiaBlood, 2000
- Chronic myeloid leukemia from basics to bedsideLeukemia, 1999
- Prognostic Significance of c-ABL Methylation in Chronic Myelogenous Leukemia: Still an Open QuestionBlood, 1999
- Location of theBCR-ABL fusion gene on the 9q34 band in two cases of Ph-positive chronic myeloid leukemiaGenes, Chromosomes and Cancer, 1997
- Improved Sensitivity of BCR-ABL Detection: A Triple-Probe Three-Color Fluorescence In Situ Hybridization SystemBlood, 1997
- The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment]Blood, 1996
- Clinical Relevance of the Breakpoint Sites within the M-BCR in 50 Patients from Argentina with Chronic Myeloid LeukemiaLeukemia & Lymphoma, 1996
- Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α TherapyAnnals of Internal Medicine, 1995
- The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALLCancer Genetics and Cytogenetics, 1993